These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9593558

  • 1. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study.
    Michels KB, Rosner BA, Manson JE, Stampfer MJ, Walker AM, Willett WC, Hennekens CH.
    Circulation; 1998 Apr 28; 97(16):1540-8. PubMed ID: 9593558
    [Abstract] [Full Text] [Related]

  • 2. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 3. Beta-blockers for hypertension.
    Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD002003. PubMed ID: 17253471
    [Abstract] [Full Text] [Related]

  • 4. The risk of myocardial infarction associated with antihypertensive drug therapies.
    Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW.
    JAMA; 2007 Jan 24; 274(8):620-5. PubMed ID: 7637142
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB, Rosner BA, Walker AM, Stampfer MJ, Manson JE, Colditz GA, Hennekens CH, Willett WC.
    Cancer; 1998 Nov 01; 83(9):2003-7. PubMed ID: 9806660
    [Abstract] [Full Text] [Related]

  • 6. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Ledingham JG, Petrie JC, Webster J.
    J Hum Hypertens; 1997 Apr 01; 11(4):205-11. PubMed ID: 9185024
    [Abstract] [Full Text] [Related]

  • 7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W, Löwel H, Lewis M, Hörmann A.
    Eur Heart J; 1996 Aug 11; 17(8):1199-206. PubMed ID: 8869861
    [Abstract] [Full Text] [Related]

  • 9. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE.
    Lancet; 2000 Jul 29; 356(9227):359-65. PubMed ID: 10972367
    [Abstract] [Full Text] [Related]

  • 10. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.
    JAMA; 2003 May 21; 289(19):2534-44. PubMed ID: 12759325
    [Abstract] [Full Text] [Related]

  • 11. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding.
    Kaplan RC, Heckbert SR, Koepsell TD, Rosendaal FR, Psaty BM.
    Arch Intern Med; 2000 Jun 26; 160(12):1849-55. PubMed ID: 10871980
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive patients: a meta-analysis.
    Rimoldi SF, Messerli FH, Chavez P, Stefanini GG, Scherrer U.
    J Clin Hypertens (Greenwich); 2015 Mar 26; 17(3):193-9. PubMed ID: 25556777
    [Abstract] [Full Text] [Related]

  • 13. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL, Baker WL, White CM.
    Curr Med Res Opin; 2007 Jun 26; 23(6):1239-44. PubMed ID: 17559720
    [Abstract] [Full Text] [Related]

  • 14. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
    Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD.
    JAMA; 1997 Mar 05; 277(9):739-45. PubMed ID: 9042847
    [Abstract] [Full Text] [Related]

  • 15. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Sever PS, Chang CL, Prescott MF, Gupta A, Poulter NR, Whitehouse A, Scanlon M.
    Eur Heart J; 2012 Dec 05; 33(23):2970-9. PubMed ID: 22942337
    [Abstract] [Full Text] [Related]

  • 16. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S, Mallick R, Roht L.
    J Hum Hypertens; 2001 Mar 05; 15(3):153-9. PubMed ID: 11317198
    [Abstract] [Full Text] [Related]

  • 17. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW, McElduff P, Dobson A, Heller R.
    J Am Coll Cardiol; 1998 Jan 05; 31(1):111-7. PubMed ID: 9426027
    [Abstract] [Full Text] [Related]

  • 18. First-line drugs for hypertension.
    Wright JM, Musini VM.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD001841. PubMed ID: 19588327
    [Abstract] [Full Text] [Related]

  • 19. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ, INVEST Investigators.
    Am J Cardiovasc Drugs; 2007 Jul 08; 7 Suppl 1():25-9. PubMed ID: 19845074
    [Abstract] [Full Text] [Related]

  • 20. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L.
    JAMA; 1997 Jan 08; 277(2):115-21. PubMed ID: 8990335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.